HEADER HYDROLASE 31-OCT-06 2NQG TITLE CALPAIN 1 PROTEOLYTIC CORE INACTIVATED BY WR18(S,S), AN EPOXYSUCCINYL- TITLE 2 TYPE INHIBITOR. COMPND MOL_ID: 1; COMPND 2 MOLECULE: CALPAIN-1 CATALYTIC SUBUNIT; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CALPAIN CATALYTIC DOMAIN, RESIDUES 27-356; COMPND 5 SYNONYM: CALPAIN-1 LARGE SUBUNIT, CALCIUM-ACTIVATED NEUTRAL COMPND 6 PROTEINASE 1, CANP 1, CALPAIN MU-TYPE, MUCANP, MICROMOLAR-CALPAIN; COMPND 7 EC: 3.4.22.52; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 GENE: CAPN1, CLS1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET24D KEYWDS EPOXIDE, EPOXYSUCCINYL, PROTEASE, PEPTIDASE, PROTEINASE, INACTIVATOR, KEYWDS 2 INHIBITOR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR D.CUERRIER,P.L.DAVIES,R.L.CAMPBELL,T.MOLDOVEANU REVDAT 5 30-AUG-23 2NQG 1 REMARK SEQADV LINK REVDAT 4 18-OCT-17 2NQG 1 REMARK REVDAT 3 24-FEB-09 2NQG 1 VERSN REVDAT 2 10-APR-07 2NQG 1 JRNL REVDAT 1 09-JAN-07 2NQG 0 JRNL AUTH D.CUERRIER,T.MOLDOVEANU,R.L.CAMPBELL,J.KELLY,B.YORUK, JRNL AUTH 2 S.H.L.VERHELST,D.GREENBAUM,M.BOGYO,P.L.DAVIES JRNL TITL DEVELOPMENT OF CALPAIN-SPECIFIC INACTIVATORS BY SCREENING OF JRNL TITL 2 POSITIONAL SCANNING EPOXIDE LIBRARIES JRNL REF J.BIOL.CHEM. V. 282 9600 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17218315 JRNL DOI 10.1074/JBC.M610372200 REMARK 2 REMARK 2 RESOLUTION. 2.04 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.04 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.10 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 88.1 REMARK 3 NUMBER OF REFLECTIONS : 17455 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 927 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.04 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.09 REMARK 3 REFLECTION IN BIN (WORKING SET) : 974 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 68.05 REMARK 3 BIN R VALUE (WORKING SET) : 0.1980 REMARK 3 BIN FREE R VALUE SET COUNT : 42 REMARK 3 BIN FREE R VALUE : 0.3520 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2594 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 126 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.39 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.51000 REMARK 3 B22 (A**2) : 0.34000 REMARK 3 B33 (A**2) : 0.17000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.261 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.218 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.132 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.686 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.938 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.888 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2745 ; 0.019 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3723 ; 1.675 ; 1.951 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 323 ; 7.207 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 139 ;37.727 ;24.388 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 455 ;16.211 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;17.962 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 394 ; 0.123 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2121 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1195 ; 0.221 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1818 ; 0.306 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 152 ; 0.156 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 2 ; 0.303 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 67 ; 0.218 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 10 ; 0.185 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1666 ; 1.085 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2602 ; 1.756 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1283 ; 2.515 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1121 ; 3.778 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2NQG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-NOV-06. REMARK 100 THE DEPOSITION ID IS D_1000040177. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-APR-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC CONFOCAL MIRRORS REMARK 200 OPTICS : OSMIC CONFOCAL MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17455 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.040 REMARK 200 RESOLUTION RANGE LOW (A) : 110.430 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.1 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.07900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.04 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.12 REMARK 200 COMPLETENESS FOR SHELL (%) : 59.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.32500 REMARK 200 R SYM FOR SHELL (I) : 0.32500 REMARK 200 FOR SHELL : 4.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2G8J REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.45 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: EXPANSION AROUND 1.1-1.7 M NACL, 10 MM REMARK 280 CACL2, AND 0.1 M MES (PH 6.0), VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.27700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.09300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.29400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.09300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.27700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.29400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 26 REMARK 465 GLY A 27 REMARK 465 LEU A 28 REMARK 465 GLY A 29 REMARK 465 ARG A 30 REMARK 465 HIS A 31 REMARK 465 GLU A 32 REMARK 465 PRO A 355 REMARK 465 ASP A 356 REMARK 465 LEU A 357 REMARK 465 GLU A 358 REMARK 465 HIS A 359 REMARK 465 HIS A 360 REMARK 465 HIS A 361 REMARK 465 HIS A 362 REMARK 465 HIS A 363 REMARK 465 HIS A 364 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 46 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 61 69.90 -160.79 REMARK 500 LYS A 71 -76.80 -140.11 REMARK 500 GLN A 142 -115.44 -103.89 REMARK 500 ALA A 146 30.66 -142.04 REMARK 500 PHE A 177 -139.13 -100.92 REMARK 500 THR A 218 -32.40 -132.80 REMARK 500 ILE A 257 -83.68 122.34 REMARK 500 ARG A 258 43.83 -149.83 REMARK 500 LEU A 260 14.85 -148.10 REMARK 500 GLU A 261 165.43 79.97 REMARK 500 VAL A 301 94.62 75.16 REMARK 500 TRP A 303 134.36 -39.05 REMARK 500 TRP A 307 -6.98 79.47 REMARK 500 GLU A 330 86.03 -69.34 REMARK 500 LEU A 353 -162.56 -101.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 401 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 VAL A 99 O REMARK 620 2 GLY A 101 O 80.3 REMARK 620 3 ASP A 106 OD1 155.5 122.0 REMARK 620 4 ASP A 106 OD2 155.1 80.3 48.9 REMARK 620 5 GLU A 185 OE1 101.3 132.3 72.0 80.7 REMARK 620 6 GLU A 185 OE2 81.5 84.9 108.5 81.3 49.2 REMARK 620 7 HOH A 518 O 91.4 75.8 85.3 98.8 150.5 160.3 REMARK 620 8 HOH A 612 O 73.5 145.4 82.0 130.2 75.8 112.5 82.6 REMARK 620 N 1 2 3 4 5 6 7 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 402 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 302 OE1 REMARK 620 2 GLU A 302 OE2 50.8 REMARK 620 3 ASP A 309 OD2 79.7 129.3 REMARK 620 4 ASP A 309 OD1 86.4 114.5 42.6 REMARK 620 5 MET A 329 O 113.2 82.4 113.0 71.6 REMARK 620 6 ASP A 331 OD1 119.1 72.6 156.7 143.5 74.2 REMARK 620 7 GLU A 333 O 84.1 94.8 89.4 132.1 153.2 79.6 REMARK 620 8 HOH A 627 O 162.0 145.5 85.1 88.8 81.5 73.8 86.3 REMARK 620 N 1 2 3 4 5 6 7 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NQG A 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2NQI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE SAME PROTEIN FRAGMENT, INACTIVATED BY REMARK 900 WR13(R,R), ANOTHER EPOXYSUCCINYL INHIBITOR WITH OPPOSITE REMARK 900 STEREOCHEMISTRY. REMARK 900 RELATED ID: 1TLO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE SAME PROTEIN FRAGMENT, INACTIVATED BY E-64, REMARK 900 ANOTHER EPOXYSUCCINYL INHIBITOR. REMARK 900 RELATED ID: 2G8J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE SAME PROTEIN FRAGMENT, COMPLEXED WITH SNJ- REMARK 900 1945, AN ALPHA-KETOAMIDE INHIBITOR. REMARK 900 RELATED ID: 2G8E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE SAME PROTEIN FRAGMENT, COMPLEXED WITH SNJ- REMARK 900 1715, A CYCLIC HEMIACETAL INHIBITOR. REMARK 900 RELATED ID: 1TL9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE SAME PROTEIN FRAGMENT, COMPLEXED WITH REMARK 900 LEUPEPTIN, AN ALDEHYDE INHIBITOR. REMARK 900 RELATED ID: 1ZCM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN ISOFORM OF THE SAME PROTEIN FRAGMENT, REMARK 900 INACTIVATED BY Z-LLY-FMK, A FLUOROMETHYL KETONE INHIBITOR. REMARK 900 RELATED ID: 1KXR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE SAME PROTEIN FRAGMENT, UNCOMPLEXED. DBREF 2NQG A 27 356 UNP P97571 CAN1_RAT 27 356 SEQADV 2NQG MET A 26 UNP P97571 INITIATING METHIONINE SEQADV 2NQG LEU A 357 UNP P97571 CLONING ARTIFACT SEQADV 2NQG GLU A 358 UNP P97571 CLONING ARTIFACT SEQADV 2NQG HIS A 359 UNP P97571 EXPRESSION TAG SEQADV 2NQG HIS A 360 UNP P97571 EXPRESSION TAG SEQADV 2NQG HIS A 361 UNP P97571 EXPRESSION TAG SEQADV 2NQG HIS A 362 UNP P97571 EXPRESSION TAG SEQADV 2NQG HIS A 363 UNP P97571 EXPRESSION TAG SEQADV 2NQG HIS A 364 UNP P97571 EXPRESSION TAG SEQRES 1 A 339 MET GLY LEU GLY ARG HIS GLU ASN ALA ILE LYS TYR LEU SEQRES 2 A 339 GLY GLN ASP TYR GLU ASN LEU ARG ALA ARG CYS LEU GLN SEQRES 3 A 339 ASN GLY VAL LEU PHE GLN ASP ASP ALA PHE PRO PRO VAL SEQRES 4 A 339 SER HIS SER LEU GLY PHE LYS GLU LEU GLY PRO ASN SER SEQRES 5 A 339 SER LYS THR TYR GLY ILE LYS TRP LYS ARG PRO THR GLU SEQRES 6 A 339 LEU LEU SER ASN PRO GLN PHE ILE VAL ASP GLY ALA THR SEQRES 7 A 339 ARG THR ASP ILE CYS GLN GLY ALA LEU GLY ASP CYS TRP SEQRES 8 A 339 LEU LEU ALA ALA ILE ALA SER LEU THR LEU ASN GLU THR SEQRES 9 A 339 ILE LEU HIS ARG VAL VAL PRO TYR GLY GLN SER PHE GLN SEQRES 10 A 339 GLU GLY TYR ALA GLY ILE PHE HIS PHE GLN LEU TRP GLN SEQRES 11 A 339 PHE GLY GLU TRP VAL ASP VAL VAL VAL ASP ASP LEU LEU SEQRES 12 A 339 PRO THR LYS ASP GLY LYS LEU VAL PHE VAL HIS SER ALA SEQRES 13 A 339 GLN GLY ASN GLU PHE TRP SER ALA LEU LEU GLU LYS ALA SEQRES 14 A 339 TYR ALA LYS VAL ASN GLY SER TYR GLU ALA LEU SER GLY SEQRES 15 A 339 GLY CYS THR SER GLU ALA PHE GLU ASP PHE THR GLY GLY SEQRES 16 A 339 VAL THR GLU TRP TYR ASP LEU GLN LYS ALA PRO SER ASP SEQRES 17 A 339 LEU TYR GLN ILE ILE LEU LYS ALA LEU GLU ARG GLY SER SEQRES 18 A 339 LEU LEU GLY CYS SER ILE ASN ILE SER ASP ILE ARG ASP SEQRES 19 A 339 LEU GLU ALA ILE THR PHE LYS ASN LEU VAL ARG GLY HIS SEQRES 20 A 339 ALA TYR SER VAL THR ASP ALA LYS GLN VAL THR TYR GLN SEQRES 21 A 339 GLY GLN ARG VAL ASN LEU ILE ARG MET ARG ASN PRO TRP SEQRES 22 A 339 GLY GLU VAL GLU TRP LYS GLY PRO TRP SER ASP ASN SER SEQRES 23 A 339 TYR GLU TRP ASN LYS VAL ASP PRO TYR GLU ARG GLU GLN SEQRES 24 A 339 LEU ARG VAL LYS MET GLU ASP GLY GLU PHE TRP MET SER SEQRES 25 A 339 PHE ARG ASP PHE ILE ARG GLU PHE THR LYS LEU GLU ILE SEQRES 26 A 339 CYS ASN LEU THR PRO ASP LEU GLU HIS HIS HIS HIS HIS SEQRES 27 A 339 HIS HET CA A 401 1 HET CA A 402 1 HET NQG A 501 44 HETNAM CA CALCIUM ION HETNAM NQG 5-AZANYLIDYNE-N-[(2S)-4-ETHOXY-2-HYDROXY-4- HETNAM 2 NQG OXOBUTANOYL]-L-NORVALYL-L-ARGINYL-L-TRYPTOPHANAMIDE FORMUL 2 CA 2(CA 2+) FORMUL 4 NQG C28 H39 N9 O7 FORMUL 5 HOH *126(H2 O) HELIX 1 1 LEU A 38 GLN A 40 5 3 HELIX 2 2 ASP A 41 ASN A 52 1 12 HELIX 3 3 VAL A 64 GLY A 69 1 6 HELIX 4 4 SER A 77 GLY A 82 1 6 HELIX 5 5 ARG A 87 LEU A 92 1 6 HELIX 6 6 THR A 103 ILE A 107 5 5 HELIX 7 7 ASP A 114 THR A 125 1 12 HELIX 8 8 ASN A 127 VAL A 135 1 9 HELIX 9 9 PHE A 186 GLY A 200 1 15 HELIX 10 10 TYR A 202 SER A 206 5 5 HELIX 11 11 CYS A 209 PHE A 217 1 9 HELIX 12 12 GLN A 228 ALA A 230 5 3 HELIX 13 13 ASP A 233 ARG A 244 1 12 HELIX 14 14 TYR A 312 VAL A 317 5 6 HELIX 15 15 ASP A 318 ARG A 326 1 9 HELIX 16 16 PHE A 338 PHE A 345 1 8 SHEET 1 A 3 ILE A 35 LYS A 36 0 SHEET 2 A 3 GLU A 158 ASP A 165 1 O ASP A 161 N ILE A 35 SHEET 3 A 3 ILE A 148 GLN A 155 -1 N PHE A 151 O VAL A 162 SHEET 1 B 3 LYS A 84 LYS A 86 0 SHEET 2 B 3 LEU A 168 LYS A 171 -1 O THR A 170 N LYS A 84 SHEET 3 B 3 LYS A 174 LEU A 175 -1 O LYS A 174 N LYS A 171 SHEET 1 C 6 VAL A 221 ASP A 226 0 SHEET 2 C 6 LYS A 347 ASN A 352 -1 O LEU A 348 N TYR A 225 SHEET 3 C 6 LEU A 247 SER A 251 -1 N LEU A 247 O CYS A 351 SHEET 4 C 6 TYR A 274 TYR A 284 -1 O TYR A 274 N CYS A 250 SHEET 5 C 6 GLN A 287 ARG A 295 -1 O GLN A 287 N TYR A 284 SHEET 6 C 6 GLU A 333 SER A 337 -1 O PHE A 334 N MET A 294 LINK SG CYS A 115 CBT NQG A 501 1555 1555 1.81 LINK O VAL A 99 CA CA A 401 1555 1555 2.46 LINK O GLY A 101 CA CA A 401 1555 1555 2.43 LINK OD1 ASP A 106 CA CA A 401 1555 1555 2.58 LINK OD2 ASP A 106 CA CA A 401 1555 1555 2.67 LINK OE1 GLU A 185 CA CA A 401 1555 1555 2.72 LINK OE2 GLU A 185 CA CA A 401 1555 1555 2.59 LINK OE1 GLU A 302 CA CA A 402 1555 1555 2.52 LINK OE2 GLU A 302 CA CA A 402 1555 1555 2.49 LINK OD2 ASP A 309 CA CA A 402 1555 1555 3.27 LINK OD1 ASP A 309 CA CA A 402 1555 1555 2.56 LINK O MET A 329 CA CA A 402 1555 1555 2.49 LINK OD1 ASP A 331 CA CA A 402 1555 1555 2.45 LINK O GLU A 333 CA CA A 402 1555 1555 2.33 LINK CA CA A 401 O HOH A 518 1555 1555 2.45 LINK CA CA A 401 O HOH A 612 1555 1555 2.59 LINK CA CA A 402 O HOH A 627 1555 1555 2.00 SITE 1 AC1 6 VAL A 99 GLY A 101 ASP A 106 GLU A 185 SITE 2 AC1 6 HOH A 518 HOH A 612 SITE 1 AC2 6 GLU A 302 ASP A 309 MET A 329 ASP A 331 SITE 2 AC2 6 GLU A 333 HOH A 627 SITE 1 AC3 20 GLN A 109 GLY A 113 ASP A 114 CYS A 115 SITE 2 AC3 20 TRP A 116 GLY A 207 GLY A 208 CYS A 209 SITE 3 AC3 20 THR A 210 SER A 251 ILE A 252 ASN A 253 SITE 4 AC3 20 GLY A 271 HIS A 272 GLN A 287 TRP A 298 SITE 5 AC3 20 ARG A 339 LYS A 347 HOH A 544 HOH A 571 CRYST1 40.554 70.588 110.186 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024659 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014167 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009076 0.00000